CVE-2019-13539: CWE-328 in Medtronic Valleylab Exchange Client
Medtronic Valleylab Exchange Client version 3.4 and below, Valleylab FT10 Energy Platform (VLFT10GEN) software version 4.0.0 and below, and Valleylab FX8 Energy Platform (VLFX8GEN) software version 1.1.0 and below use the descrypt algorithm for OS password hashing. While interactive, network-based logons are disabled, and attackers can use the other vulnerabilities within this report to obtain local shell access and access these hashes.
AI Analysis
Technical Summary
CVE-2019-13539 identifies a security vulnerability in Medtronic's Valleylab Exchange Client and associated Valleylab Energy Platform software versions 3.4 and below (Exchange Client), 4.0.0 and below (FT10 Energy Platform), and 1.1.0 and below (FX8 Energy Platform). The core issue is the use of the outdated and cryptographically weak descrypt algorithm for operating system password hashing. DES-based hashing algorithms like descrypt are vulnerable to modern cracking techniques due to their limited key size and computational weaknesses, making it feasible for attackers to recover plaintext passwords from hashes. Although interactive and network-based logons are disabled on these systems, which limits direct remote exploitation, the vulnerability becomes critical when combined with other weaknesses that allow an attacker to gain local shell access. Once local access is obtained, an attacker can extract the password hashes and attempt offline cracking attacks to escalate privileges or move laterally within the environment. The vulnerability is classified under CWE-328, which concerns the use of weak cryptographic primitives. The CVSS v3.1 base score is 7.0 (high severity), reflecting high impact on confidentiality, integrity, and availability, but with limited attack vector (local) and requiring some privileges. No known exploits in the wild have been reported, and no patches are linked in the provided data, indicating that remediation may require vendor engagement or manual mitigation. This vulnerability affects critical medical device software used in surgical and energy platform systems, which are integral to healthcare operations and patient safety.
Potential Impact
For European organizations, especially healthcare providers and hospitals using Medtronic Valleylab products, this vulnerability poses a significant risk. Compromise of these systems could lead to unauthorized access to sensitive medical device controls and patient data, potentially disrupting surgical procedures or causing device malfunction. The confidentiality of patient information could be breached, violating GDPR requirements and leading to legal and reputational consequences. Integrity and availability impacts could affect the reliability of medical treatments, posing direct risks to patient safety. Since these devices are often integrated into hospital networks, exploitation could serve as a foothold for attackers to pivot to other critical infrastructure within healthcare facilities. The high severity score underscores the need for urgent attention despite the lack of known active exploitation. The local access requirement means that insider threats or attackers who have already breached perimeter defenses pose the greatest risk.
Mitigation Recommendations
European healthcare organizations should implement a layered defense strategy. First, ensure strict physical and network access controls to prevent unauthorized local access to these devices. Segment medical device networks from general IT networks to limit lateral movement. Conduct thorough audits to identify all affected Medtronic Valleylab devices and verify software versions. Engage with Medtronic for official patches or firmware updates; if unavailable, consider compensating controls such as enhanced monitoring and anomaly detection on device communications and user activities. Employ strong endpoint protection on systems interfacing with these devices. Regularly update and enforce strong password policies and consider multi-factor authentication where possible for device access. Additionally, conduct staff training to raise awareness about insider threats and the importance of securing medical devices. Finally, maintain incident response plans tailored to medical device compromise scenarios to ensure rapid containment and recovery.
Affected Countries
Germany, France, United Kingdom, Italy, Spain, Netherlands, Sweden, Belgium
CVE-2019-13539: CWE-328 in Medtronic Valleylab Exchange Client
Description
Medtronic Valleylab Exchange Client version 3.4 and below, Valleylab FT10 Energy Platform (VLFT10GEN) software version 4.0.0 and below, and Valleylab FX8 Energy Platform (VLFX8GEN) software version 1.1.0 and below use the descrypt algorithm for OS password hashing. While interactive, network-based logons are disabled, and attackers can use the other vulnerabilities within this report to obtain local shell access and access these hashes.
AI-Powered Analysis
Technical Analysis
CVE-2019-13539 identifies a security vulnerability in Medtronic's Valleylab Exchange Client and associated Valleylab Energy Platform software versions 3.4 and below (Exchange Client), 4.0.0 and below (FT10 Energy Platform), and 1.1.0 and below (FX8 Energy Platform). The core issue is the use of the outdated and cryptographically weak descrypt algorithm for operating system password hashing. DES-based hashing algorithms like descrypt are vulnerable to modern cracking techniques due to their limited key size and computational weaknesses, making it feasible for attackers to recover plaintext passwords from hashes. Although interactive and network-based logons are disabled on these systems, which limits direct remote exploitation, the vulnerability becomes critical when combined with other weaknesses that allow an attacker to gain local shell access. Once local access is obtained, an attacker can extract the password hashes and attempt offline cracking attacks to escalate privileges or move laterally within the environment. The vulnerability is classified under CWE-328, which concerns the use of weak cryptographic primitives. The CVSS v3.1 base score is 7.0 (high severity), reflecting high impact on confidentiality, integrity, and availability, but with limited attack vector (local) and requiring some privileges. No known exploits in the wild have been reported, and no patches are linked in the provided data, indicating that remediation may require vendor engagement or manual mitigation. This vulnerability affects critical medical device software used in surgical and energy platform systems, which are integral to healthcare operations and patient safety.
Potential Impact
For European organizations, especially healthcare providers and hospitals using Medtronic Valleylab products, this vulnerability poses a significant risk. Compromise of these systems could lead to unauthorized access to sensitive medical device controls and patient data, potentially disrupting surgical procedures or causing device malfunction. The confidentiality of patient information could be breached, violating GDPR requirements and leading to legal and reputational consequences. Integrity and availability impacts could affect the reliability of medical treatments, posing direct risks to patient safety. Since these devices are often integrated into hospital networks, exploitation could serve as a foothold for attackers to pivot to other critical infrastructure within healthcare facilities. The high severity score underscores the need for urgent attention despite the lack of known active exploitation. The local access requirement means that insider threats or attackers who have already breached perimeter defenses pose the greatest risk.
Mitigation Recommendations
European healthcare organizations should implement a layered defense strategy. First, ensure strict physical and network access controls to prevent unauthorized local access to these devices. Segment medical device networks from general IT networks to limit lateral movement. Conduct thorough audits to identify all affected Medtronic Valleylab devices and verify software versions. Engage with Medtronic for official patches or firmware updates; if unavailable, consider compensating controls such as enhanced monitoring and anomaly detection on device communications and user activities. Employ strong endpoint protection on systems interfacing with these devices. Regularly update and enforce strong password policies and consider multi-factor authentication where possible for device access. Additionally, conduct staff training to raise awareness about insider threats and the importance of securing medical devices. Finally, maintain incident response plans tailored to medical device compromise scenarios to ensure rapid containment and recovery.
Affected Countries
For access to advanced analysis and higher rate limits, contact root@offseq.com
Technical Details
- Data Version
- 5.1
- Assigner Short Name
- icscert
- Date Reserved
- 2019-07-11T00:00:00
- Cisa Enriched
- false
- Cvss Version
- 3.1
- State
- PUBLISHED
Threat ID: 682f866a0acd01a249266e5f
Added to database: 5/22/2025, 8:17:46 PM
Last enriched: 7/8/2025, 6:09:48 AM
Last updated: 7/31/2025, 12:41:55 PM
Views: 13
Related Threats
Researcher to release exploit for full auth bypass on FortiWeb
HighCVE-2025-9091: Hard-coded Credentials in Tenda AC20
LowCVE-2025-9090: Command Injection in Tenda AC20
MediumCVE-2025-9092: CWE-400 Uncontrolled Resource Consumption in Legion of the Bouncy Castle Inc. Bouncy Castle for Java - BC-FJA 2.1.0
LowCVE-2025-9089: Stack-based Buffer Overflow in Tenda AC20
HighActions
Updates to AI analysis are available only with a Pro account. Contact root@offseq.com for access.
Need enhanced features?
Contact root@offseq.com for Pro access with improved analysis and higher rate limits.